Essential phospholipids: old physical substances – new production technology
Abstract
The aim of review. To present technological innovations in production of new drugs on the basis of essential phospholipids (EPL)
Original positions. The positive effect of EPL is known for over 100 years. For over 50 years commercial drugs on a basis EPL are applied, their efficacy is proven by numerous clinical and experimental studies. However, traditionally used technologies of treatment of EPL substance by active oxygen at production effecting drugs are not optimal, as they are accompanied by formation of hydroperoxides having potential toxicity. The alternative method used at production of new drug on EPL basis (RESALUT Pro), provides treatment of phospholipid substances by liquid nitrogen that allows to keep beneficial properties of natural (native) product.
Conclusion. The new technology utilised by treatment of agent on EPL basis (RESALUT Pro), is progressive, promoting improvement of safety profile and expected clinical effect.
References
1. Буеверов А.О., Ешану В.С., Маевская М.В., Ивашкин В.Т. Эссенциальные фосфолипиды в комплексной терапии стеатогепатита смешанного генеза // Клин. перспективы гастроэнтерол. гепатол. – 2008. – № 1. – С. 17–22.
2. Best C.H., Huntsman M.E. Effect of choline on liver fat of rats in various states on nutrition // J. Physiol. – 1935. – Vol. 83. – P. 255–274.
3. Best C.H., Huntsman M.E. The effects of the components of lecithin upon the deposition of fat in the liver // J. Physiol. – 1932. – Vol. 75. – P 405–412.
4. Buchman A.L., Dubin M., Jenden D. et al. Lecithin increases plasma free choline and decreases hepatic steatosis in long-term total parenteral nutrition patients // Gastroenterology. – 1992. – Vol. 102. – P. 1363–1370.
5. DaCosta K.A., Cochary E.F., Blusztajn J.K. et al. Accumulation of 1,20sn-diradylglycerol with increased membrane-associated protein kinase C may be the mechanism for spontaneous hepatocarcinogenesis in choline deficient rats // J. Biol. Chem. – 1993. – Vol. 268. – P. 2100–2105.
6. Davis A. Let’s eat right to keep fit. – New York: Penguin, USA, 1970.
7. Davis S.S., Illum L. Use of phospholipids in drug delivery / Eds. G. Cevc, F. Paltauf // Phospholipids: Characterization, metabolism and Novel biological application. – Champaign, IL: American Oil Chemists’ Society Press, 1995. – P. 67–79.
8. Hsia S.L., He J.L., Mandel M., Froelich C.W. Lowering serum cholesterol by topical treatment with soy phosphatidylcholine // Presented at: 7th International Congress on Phospholipids; Monday, Sep.9, 1996; Brussels, Belgium.
9. Hsia S.L., He J.L., Nie Y. et al. The hypocholesterolemic and antiatherogenic effects of topically applied phosphatidylcholine in rabbits with heritable hypercholesterolemia // Artery. – 1996. – Vol. 22. – P. 1–23.
10. Lehtinen P., Laakso S. Role of lipid reactions in quality of oat products // Agricultural and food science. – 2004. – Vol. 13. – P. 88–89.
11. Lieber C.S., DeCarli L.M., Mak K.M. et al. Attenuation of alcohol-induced hepatic fibrosis by polyunsaturated lecithin // Hepatology. – 1990. – Vol. 12. – P. 1390–1398.
12. Lieber C.S., Robins S.J., Li J. et al. Phosphatidylcholine protects against fibrosis and cirrhosis in the baboon // Gastroenterology. – 1994. – Vol. 106. – P. 152–159.
13. Locker J., Reddy T.V., Lombardi B. DNA methylation and hepatocarcinogenesis in rats fed a choline-devoid diet // Carcinogenesis. – 1986. – Vol. 7. – P. 1309–1312.
14. Newberne P.M., Rogers A.E. Labile methyl groups and the promotion of cancer // Am. J. Clin. Nutr. – 1986. – Vol. 6. – P. 407–432.
15. O’Brien B.C., Andews V.G. Influence of dietary egg and soybean phospholipids and triacylglycerols on human serum lipoproteins // Lipids. – 1993. – Vol. 28. – P. 7–12.
16. Sheard N.F., Tayek J.A., Bistrian B.R. et al. Plasma choline concentration in humans fed parenterally // Am. J. Clin. Nutr. – 1986. – Vol. 43. – P. 219–224.
17. Strecker A. Uber einige neue Bestandtheile der Schweingalle // Ann. Chem. Pharmacie. – 1862. – Vol. 123. – P. 353–360.
18. USDA. Continuing Survey of food intakes by individuals, 1989–91. – Washington, DC: United States Department of Agriculture, 1992.
19. USDA. USDA Nationwide Food Consumption Survey, 1977–78. – Washington, DC: United States Department of Agriculture, 1979.
20. Wurtman R.T. Phosphatidylcholine in neurologic disorders // Choline phospholipids: molecular mechanisms for human disease. Satellite conference, University of North Carolina/American Institute of Nutrition; Friday, Apr. 3, 1992; San Diego, CA.
21. Yates J. Lecithin works wonders // Prevention. February. – 1980. – Vol. 32. – P. 55–59.
22. Zeisei S.H. Choline / Eds. M.E. Shils, J.A. Olson, M. Shike. Modern nutrition in health and disease. – 8th ed. – Philadelphia: Lea & Febiger, 1994. – P. 449–458.
23. Zeisei S.H. Choline phospholipids: signal transduction and carcinogenesis // FASEB J. – 1993. – Vol.7. – 551–557.
24. Zeisei S.H. Choline: an important nutrient in brain development, liver function and carcinogenesis // J. Am. Coll. Nutr. – 1992. – Vol. 11. – P. 473–481.
25. Zeisei S.H., DaCosta K.A., Franklin P.D. Choline, an essencial nutrient for humans // FASEB J. – 1991. – Vol. 5. – P. 2093–2098.
Review
For citations:
Uspensky Yu.P. Essential phospholipids: old physical substances – new production technology. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2009;19(5):24-28. (In Russ.)
Views:
11
Email this article 
